Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus etomidate + propofol for painless gastroscopy sedation in older adults
ChiCTR2000038026Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guizhou University of Chinese Medicine
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, etomidate, propofol and remifentanil in None (2 arms), sponsored by First Affiliated Hospital of Guizhou University of Chinese Medicine. Primary endpoints: Throat reflexes, Facial expressions and 1 more. Started Oct 2020; status: recruiting.
02
Drugs
remimazolametomidatepropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2000038026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038026.